Frankfurt - Delayed Quote EUR
Opus Genetics, Inc. (R3X1.F)
0.8840
-0.0090
(-1.01%)
At close: June 10 at 9:55:02 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
13,651
10,992
19,049
39,850
589
Operating Expense
49,946
45,066
29,612
21,624
23,294
Operating Income
-36,295
-34,074
-10,563
18,226
-22,705
Net Non Operating Interest Income Expense
-1,372
0
-1,328
-9
-2
Other Income Expense
-20,953
-23,458
1,917
-14
-33,986
Pretax Income
-58,620
-57,532
-9,974
18,203
-56,693
Tax Provision
0
0
12
315
0
Net Income Common Stockholders
-58,620
-57,532
-9,986
17,888
-56,693
Diluted NI Available to Com Stockholders
-58,620
-57,532
-9,986
17,888
-56,693
Basic EPS
-2.10
-2.15
-0.46
0.90
-3.82
Diluted EPS
-2.10
-2.15
-0.46
0.87
-3.82
Basic Average Shares
29,056.6370
26,715.5260
21,589.8210
19,931.0800
14,852.7450
Diluted Average Shares
29,056.6370
26,715.5260
21,589.8210
20,597.2120
14,852.7450
Total Operating Income as Reported
-64,295
-62,074
-10,563
18,226
-22,705
Total Expenses
49,946
45,066
29,612
21,624
23,294
Net Income from Continuing & Discontinued Operation
-58,620
-57,532
-9,986
17,888
-56,693
Normalized Income
-33,497
-29,604
-10,049.2000
17,888
-22,864
Interest Expense
1,372
0
1,328
9
2
Net Interest Income
-1,372
0
-1,328
-9
-2
EBIT
-57,248
-57,532
-8,646
18,212
-56,691
EBITDA
-57,225
-57,522
-8,640
18,216
-56,687
Reconciled Depreciation
23
10
6
4
4
Net Income from Continuing Operation Net Minority Interest
-58,620
-57,532
-9,986
17,888
-56,693
Total Unusual Items Excluding Goodwill
-25,123
-27,928
80
--
-33,829
Total Unusual Items
-25,123
-27,928
80
--
-33,829
Normalized EBITDA
-32,102
-29,594
-8,720
18,216
-22,858
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
0
0
16.8000
0
0
12/31/2021 - 11/9/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade